Cargando…
Development and Validation of a 7-Gene Inflammatory Signature Forecasts Prognosis and Diverse Immune Landscape in Lung Adenocarcinoma
Background: Inflammatory responses are strongly linked with tumorigenesis and cancer development. This research aimed to construct and validate a novel inflammation response–related risk predictive signature for forecasting the prognosis of patients with LUAD. Methods: Differential expression analys...
Autores principales: | Nai, Aitao, Ma, Feng, He, Zirui, Zeng, Shuwen, Bashir, Shoaib, Song, Jian, Xu, Meng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964604/ https://www.ncbi.nlm.nih.gov/pubmed/35372503 http://dx.doi.org/10.3389/fmolb.2022.822739 |
Ejemplares similares
-
Identification and Validation of Immune-Related Gene Signature for Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma
por: Jia, Ran, et al.
Publicado: (2021) -
Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021) -
lncRNA/miR-29c-Mediated High Expression of LOX Can Influence the Immune Status and Chemosensitivity and Can Forecast the Poor Prognosis of Gastric Cancer
por: Nai, Aitao, et al.
Publicado: (2022) -
Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy
por: Feng, Xiaofei, et al.
Publicado: (2022) -
Identification of a Novel Tumor Microenvironment–Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma
por: Ma, Chao, et al.
Publicado: (2020)